Yes JM: Medolife Rx Now has the Attention of Savvy-Investors from Yesterdays News-Hunting for Super Cheap Shares with Great Potential Returns... FDA Accepts COVID-19 Clinical Study and Advises on Next Steps for Pre-IND Filing by Medolife Rx https://finance.yahoo.com/news/fda-accepts-covid-19-clinical-123000620.html